Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Kyowa Kirin Invests US$530 million for New Biologics Manufacturing Plant in USA
Kyowa Kirin invests US$530 million to construct a stateoftheart manufacturing facility in North Carolina, USA The 171,700squarefoot, tworeactor facility will accelerate the development
Aurigene Pharmaceutical Services Opens New Biologics Facility in India
Aurigene Pharmaceutical Services is set to open a new biologics facility in India, providing process development and clinicalscale manufacturing capabilities
Kymanox Expands Laboratory Service Offerings in USA
Kymanox is planning to expand its device design and testing facility, significantly enhancing its laboratory testing capabilities and increasing its CGxP footprint in the USA
Integrated DNA Technologies Expands New Synthetic Biology Hub in Lowa, USA
Integrated DNA Technologies plans to open new stateoftheart synthetic biology hub in Lowa, USA This expansion marks a significant enhancement of its synthetic biology
Eli Lilly Invests US$9 billion to Expand Manufacturing Site in Indiana, USA
Eli Lilly invests US$9 million in the newest Indiana site to boost API production for tirzepatide and pipeline medicines in USA This expansion will increase the capacity to manufacture active pharmaceutical ingredients
Akoya Biosciences Plans to Open Operations and Manufacturing Centre in Massachusetts, USA
Akoya Biosciences is planning to launch its stateoftheart operations and manufacturing centre of excellence in Massachusetts, USA The newly established operations and manufacturing
AstraZeneca Invests US$1.5 billion for New Manufacturing Facility in Singapore
AstraZeneca is set to invest US$15 billion to open a new manufacturing facility for antibody drug conjugates in Singapore This stateoftheart greenfield facility
PCI Pharma to Open New Sterile Fill-Finish Facility in USA
PCI Pharma Services plans to open newest sterile fillfinish facility in USAThe facility will enhance capacity with Annex 1compliant technology,
Solvias Plans to Open New Biotech Site in California, USA
Solvias plans to expand its global network to build a new biotech site in North California, USAThe new 50,000squarefoot facility will expand analytical testing services
Adare Pharma Solutions Expands High Potency Handling Capabilities in USA and Europe
Adare Pharma Solutions plans to expand its high potency handling capabilities in the United States and Europe The new facility in Philadelphia, USA
